Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
UCLB reaches an exclusive license agreement for the treatment of Alpha-1-Antitrypsin Deficiency
UCLB has concluded an exclusive agreement to license a collection of pre-clinical small molecule compounds for the treatment of alpha-1-antitrypsin deficiency with a US biotech company.
Novel method of analysis of stroke data
How does Portico Ventures support non-patentable and fast-to-deploy technologies?
As Portico Ventures is well under way at UCL, we catch up with Programme Manager Denisa Naidin on how UCLB’s work is helping to speed up the route to commercialisation for Computer Science innovations at UCL.